Skip to Main Content

Paper Details

Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy.
Nat Genet
116
2020
HGSOC, HGSOC tumors, Myc target genes, T cells, Wnt, advanced HGSOC, advanced ovarian cancer, high-grade serous ovarian cancer, immune, immune cell, metastatic cancer, natural killer (NK) cell, tumor
Author NameAffiliation
Simon KoplevCancer Research UK Cambridge Institute, University of Cambridge
Simon KoplevCancer Research UK Cambridge Institute, University of Cambridge
Danish MemonCancer Research UK Cambridge Institute, University of Cambridge
Danish MemonEuropean Bioinformatics Institute
Pier SelenicaMemorial Sloan Kettering Cancer Center
Felipe C GeyerMemorial Sloan Kettering Cancer Center
Geoff MacintyreCancer Research UK Cambridge Institute, University of Cambridge
Geoff MacintyreSpanish National Cancer Research Centre (CNIO)
Ruben M DrewsCancer Research UK Cambridge Institute, University of Cambridge
Robert A SoslowMemorial Sloan Kettering Cancer Center
Ronglai ShenMemorial Sloan Kettering Cancer Center
Travis J HollmannMemorial Sloan Kettering Cancer Center
Jorge S Reis-FilhoMemorial Sloan Kettering Cancer Center
Florian MarkowetzCancer Research UK Cambridge Institute, University of Cambridge
Florian MarkowetzCancer Research UK Cambridge Institute, University of Cambridge
Pedro BeltraoEuropean Bioinformatics Institute
James D BrentonCancer Research UK Cambridge Institute, University of Cambridge
Britta WeigeltMemorial Sloan Kettering Cancer Center
  • 1 - 18

Datasets

Release 1.2